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Abstract
The two main surgical options for patients with persistent or recurrent cubital tunnel syndrome are subcuta-
neous and submuscular transposition. We retrospectively analysed the results of 34 patients with recalcitrant
cubital tunnel syndrome who underwent submuscular transposition with musculofascial lengthening at our
institutions. Of the 34 patients, 21 improved clinically after submuscular transposition with musculofascial
lengthening, of which 16 were still satisfied at a mean follow-up of four years. In addition, all articles pub-
lished between 1974 and January 2015 on subcutaneous and/or submuscular transposition of the ulnar nerve
for recalcitrant cubital tunnel syndrome were reviewed. We found that previously published studies on this
subject are too heterogeneous to compare. No recommendation can thus be made regarding the surgical
technique for persistent or recurrent cubital tunnel syndrome. Our series shows that the musculofascial
lengthening technique for submuscular transposition is a good option. More research is needed to compare
the different surgical treatments.
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Introduction
Symptoms of cubital tunnel syndrome (CuTS) fre-
quently persist or recur after primary surgery,
about 30% in the prospective randomized trial by
Bartels et al. (2005). Revision surgery may therefore
be needed in some of these cases. Several studies
have investigated the effectiveness of subcutaneous
(SCT) or submuscular transposition (SMT) for recal-
citrant CuTS (Aleem et al., 2014; Bartels and
Grotenhuis, 2004; Broudy et al., 1978; Davis and
Bulluss, 2005; Gabel and Amadio, 1990; Goldfarb
et al., 2009; Holmberg, 1991; Rogers et al., 1991;
Sarris et al., 2002; Vogel et al., 2004). Nevertheless,
there is still no consensus on what type of anterior
transposition is best in patients with recurrent or
persistent symptoms of CuTS. The choice of either
SMT or SCT often depends on the preference and
experience of the surgeon. A potential disadvantage
of SMT is secondary compression due to shortening
of the muscle after transection, but this can be
overcome by the musculofascial- or Z-lengthening
technique (Dellon and Coert, 2004). This technique
significantly reduces the intraneural pressure com-
pared to the Learmonth technique for SMT (Dellon
et al., 1994).
In this study, we present our results for ulnar
nerve revision surgery in 34 patients using SMT
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with musculofascial lengthening. We have also
performed a literature search to try to answer the
following PICO (population, intervention, comparison,
outcome) question: ‘Which of the most widely used
surgical techniques (SMT or SCT) gives the best relief
of ulnar nerve-related symptoms in adult patients
with recurrent or persistent symptoms of CuTS?’
Patients and methods
Patient population
Between January 2003 and January 2014, a total of
40 adult patients with recurrent or persistent CuTS
were operated on in a university hospital and a large
teaching hospital. Six patients were excluded from
analysis: two who had previously had cervical spine
surgery at the C6–C7 level (because of the double
level lesion/compression); one with polyneuropathy
of the upper extremities; two with a follow up of
less than 12 months; and one who died during
follow-up due to another cause. The final study
group therefore consisted of 34 patients. All proced-
ures were performed by two experienced peripheral
nerve surgeons (J.H.C. and G.d.R.), with level 4 and 5
experience (Tang and Giddins, 2016). Both surgeons
work in the two medical centres and evaluated the
outcome pre- and postoperatively.
Patients with persistent or recurrent symptoms of
CuTS met the indications for operation. Symptoms
consisted of pain, tingling and/or progressive motor
and/or sensory loss, after one or multiple previous
procedures. Symptoms that were not relieved by the
original surgery were classified as ‘persistent’, while
those that recurred after original improvement were
classified as ‘recurrent’. For recurrences, the inter-
val from failure to revision surgery was calculated
from the time the complaints had recurred.
Although revision surgery was performed as early
as three months after the first treatment, it was usu-
ally after a longer interval (between six months and
one year).
Before revision surgery, all patients had
symptoms of CuTS. Thirty-three had paraesthesia in
the ring or little fingers, 28 had diminished sensation,
27 experienced pain in the hand, forearm or elbow,
and 24 patients had muscle weakness. For each
patient, the McGowan classification was used: grade
1 represented no muscle weakness (15 patients);
grade 2 represented motor weakness (11 patients);
and grade 3 indicated atrophy of the intrinsic
musculature (eight patients). Preoperatively, there
were no patients with limitation of elbow motion. In
eight patients, the decision to operate was based on
clinical reasons alone. Nerve conduction studies
(NCS) were performed in 24 recalcitrant cases. Ten
cases showed signs of axonal degeneration.
Ultrasonography (US) was used to localize the
compression site in six cases with a high suspicion
for ulnar neuropathy but inconclusive or negative
NCS, and confirmed the diagnosis in all six. Nine
patients with recalcitrant CuTS had clinical signs of
a concurrent neuroma or injury to the posterior
branch of the medial antebrachial cutaneous nerve
(MABCN), with three having had a previous excision
of a neuroma of this nerve. Failed primary
procedures consisted of simple decompression
(SiD) in 23 patients and SCT in one. Ten patients
had two or more previous procedures; combinations
are listed in table 1. Intra-operative findings (such as
scarring or residual compression) were recorded
from the operation notes. This study was approved
by the Medical Ethics committee. Informed consent
was obtained from all patients.
Surgical procedure and postoperative care
In all patients, submuscular transposition of the
ulnar nerve with musculofascial lengthening,
previously described by Dellon and Coert (2004),
was performed. In short: a z-lengthening incision is
made through the attachment of the flexor pronator
mass to the medial epicondyle. After transposition of
the ulnar nerve across the medial epicondyle, the
longer part of the muscular mass is re-attached to
the longer part of the tendon. This lengthening of the
muscle creates extra submuscular space for the
ulnar nerve and prevents secondary compression by
the flexor pronator mass. In cases of failed
Learmonth SMT, the flexor-pronator mass is
transected in a step-cut lengthening fashion at the
origin of both muscles. A v-shaped incision is also
made in the intermuscular septum proximal to the
medial epicondyle. The MABCN neuromas were sur-
gically excised and subsequently buried in the triceps
muscle without tension and secured with two or
three nylon sutures to prevent displacement.
Postoperative care consisted of, first, one week of
immobilization with the arm in 90 flexion, allowing
minimal forearm pronation. Subsequently, the
patients underwent two weeks of passive mobiliza-
tion in a sling, followed by three weeks of active
mobilisation without lifting objects weighing more
than 1 kg.
Clinical outcome
Clinical outcome was assessed for resolution of tin-
gling and recovery of sensation and motor weakness
(intrinsic muscles of the affected hand, adductor
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pollicis and abductor digiti minimi muscles) recorded
at the first follow-up or later times. Patients were
scored as either ‘improved’, ‘unchanged’ or
‘worsened’. ‘Improved’ patients showed clear
improvement after surgery in one or more clinical
features. Sensibility was measured by touch and
skin prick tests, and strength was scored with the
MRC muscle grading system. Successful outcome
was defined as complete or partial resolution of pre-
operative symptoms.
Subjective outcome
Long-term subjective outcome was assessed using a
modification of the questionnaire introduced by
Novak et al. (2002), which was sent to the patients
at the time of this retrospective review in 2015 and
2016. The questionnaire provides information con-
cerning pain, sensation, paraesthesia, strength, cold
intolerance and the patient’s perception of outcome
pre- and postoperatively.
Analysis of data
Pre- and postoperative symptom variables were
assessed with the McNemar test. ANOVA was used
for continuous variables and chi-squared test for cat-
egorical factors. A p-value< 0.05 was assumed to
indicate significance.
Literature review
We conducted a search on PubMed, Embase and
Cochrane libraries between January 1974 and
January 2015 using synonyms for CuTS and SCT or
SMT. Our search for titles and abstracts included:
‘(Cubital tunnel OR sulcus ulnaris OR ulnaropathy
OR ulnar nerve OR ulnar neuritis AND
(Submuscular OR subcutaneous OR transposition
OR decompression OR transposing)’. One investiga-
tor independently conducted the database search,
removing duplicates and screening all titles and
abstracts for eligibility. Then the full text was
Table 1. Demographics of patients in the study including previous operations and investigations.
Patients (n) 34
Men : women 13 : 21
Mean age, men : women (years) 49.2 : 45.8 (range 21–74)
Affected side right : left 21 : 13
Dominant side affected 16
Recurrent : persistent CuTS 11: 23
Mean previous operations 1.5 (range 1–5)
Mean objective follow-up (months) 39.8 (SD 24.0) (range 12–108)
Mean subjective (questionnaire) follow-up (months) 49.0 (SD 27.3) (range 18–108)
Mean duration of symptoms (months) 47.1 (SD 56.6) (range 9.2–225)
Mean interval between failure of prior surgery
and revision (months)
14.4 (SD 12.1) (range 2.3–53.3)
Nerve conduction study 24
Ultrasonography 6
Axonal degeneration on nerve conduction study 10
Muscle atrophy 8
Co-morbidities 13
Previous excision of a MABCN neuroma 3
 2 prior operations 10
SiD þ SCT (3)
SiD þ SMT
SiD þ 4 SCT
SiD 3 þ SCT (and silastic sheet)
SCT þ neurolysis
SCT þ neurolysis (including nerve back in sulcus)
SCT þ 2 neurolysis
SCT 3 þ neurolysis
CuTS: cubital tunnel syndrome; MABCN: medial antebrachial cutaneous nerve; SCT: subcutaneous transposition; SD: standard deviation;
SiD: simple decompression; SMT: submuscular transposition.
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reviewed. References of the final articles were
screened and included if deemed relevant. Criteria
for inclusion were randomized controlled trials or
observational studies of intervention with the SCT
or SMT technique for adult patients with recalcitrant
CuTS, using clinical and/or subjective outcome
measures.
Other characteristics including first author, study
type, publication date, patients’ characteristics (age,
sample size, surgical technique, follow-up, previous
failed interventions, intraoperative findings, persist-
ent versus recurrent cases) and outcome measure-
ments were extracted from the studies. The primary
outcome of the review was clinical or subjective
improvement after revision surgery. Confidence
intervals were calculated for the primary outcome,
and subsequently, the data were pooled (if possible)
whereby the weighted averages were calculated
(Sum [study average study cohort size 1,2. . . n/
pooled cohort size]). All included articles were
screened for risk of bias.
Results
The patient demographics are shown in Table 1.
Intraoperative findings
The following findings were predominantly present:
dense scar tissue compressing the ulnar nerve at
several levels near and at the cubital tunnel
(n = 23); nerve hyperaemia (n = 9); ulnar nerve back
in the sulcus after SCT (n = 2); incomplete releases
after SCT, SMT and SD (n = 3); and, in case of revision
after SCT, compression of the ulnar nerve at its new
position (n = 5) and pathology of the posterior branch
of the MABCN (n = 5). In five cases, there were no
aberrant findings.
Clinical outcome
At a mean clinical follow-up of 40 months, 21 of 34
patients improved after surgery, of which eight were
free of symptoms. Ten patients showed no benefit
and three were worse. Overall, the improvements
for paraesthesia, sensibility, pain and strength were
statistically significant (Table 2). Patients with
McGowan grades 2 and 3 showed a good response
for tingling and pain but less favourable recovery of
strength and sensibility. Four out of eight patients
with atrophy and four out of eight patients with
axonal degeneration had poor outcomes, as did two
patients with concomitant complex regional pain syn-
drome (CRPS). No statistical significance between
the prognostic factors in Table 1 and outcome was
observed. There was one wound infection and two
patients developed CRPS. Two out of three elbow
contractures recovered with physical therapy and
one patient had persistent elbow pain.
Subjective outcome
One patient declined and therefore 33 patients
completed the questionnaire, at a mean of 49
months after operation. Twenty patients improved
after surgery, of whom eight were free of symptoms.
These eight patients were all clinically scored as
improved. Nine patients reported no benefit and
four had got worse. Two of these four were clinically
identified as worsened. The other two were clinically
scored as unchanged or improved. Sixteen patients
were satisfied, nine were partly satisfied and eight
were not satisfied with the end result. Sensibility
improved in 16, of whom ten felt sensation had
returned to normal. Thirteen reported no change
and four were worse. Postoperative strength
improved in 15 patients, of whom six felt they had
normal strength. Fourteen reported no benefit and
four had deterioration in strength. Pain in the hand,
paraesthesia and pain at the elbow showed a statis-
tically significant improvement (p = 0.012; 0.0001;
0.0039).
Literature review
Out of a total of 729 articles retrieved, only ten retro-
spective studies (six SMT, one SCT and three mixed
SCT/SMT) met our predetermined criteria (see Figure
S1, flow diagram, online supplementary material).
These studies solely focused their intervention on
recurrent CuTS with the SCT or SMT technique (see
Table S1, literature review, online supplementary
material).
The overall objective successful outcome was in
the range of 25–75% and 20–100% for SCT and
SMT, respectively. Two studies also presented sub-
jective outcome measures. The mean pooled overall
Table 2. Cubital tunnel symptoms of patients before and
after SMT with musculofascial lengthening.
Symptoms Preoperatively Postoperatively p-value
Paraesthesia 33 (97%) 12 (35%) 0.0001
Sensory
impairment
28 (82%) 15 (44%) 0.001
Pain 27 (79%) 8 (24%) 0.0001
Strength
(weakness)
24 (71%) 16 (47%) 0.008
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improvement was 63% and 54% for SMT and SCT,
respectively. Thus, SMT seems to have a slightly
better outcome in symptom reduction. However, it
is difficult to compare the results of the various
studies because of differences in baseline character-
istics, potential selection and performance
bias (all retrospective studies), potential recall bias
(subjective outcome studies) and a wide range of dif-
ferences in outcome measures. Therefore, the
pooled results do not provide a useful value.
Discussion
The results of our series of submuscular transpos-
ition with musculofascial lengthening show good
results in patients with recalcitrant CuTS. Twenty-
one of the 34 patients (62%) improved clinically
after SMT, of which 25 (76%) were still (partly)
satisfied with the long-term outcome (mean four
years). This outcome is comparable with other previ-
ous published SMT studies, but comparison cannot
be made due to a different SMT technique being
used. Musculofascial lengthening of the flexor-pro-
nator mass significantly reduces the intraneural
pressure compared to the Learmonth technique for
SMT (Dellon et al., 1994) and therefore could be
superior to a ‘classic’ Learmonth SMT in recalcitrant
cases. Only Vogel et al. (2004) have used the same
technique and reported similar rates of 56% (10/18)
good to excellent outcome with 78% patient satisfac-
tion, although comparison is difficult because there
were more incomplete releases (retained intermus-
cular septum, arcade of Struthers, common flexor
aponeurosis), nerve instability cases and less prior
interventions in their series.
It is difficult to compare our results to those for
subcutaneous transposition, with only one study
reporting results for that technique for recalcitrant
CuTS (Caputo and Watson, 2000). In their study, resi-
dual compression was noted as the most frequent
cause of failure, while this was only the case in
three patients in our study. A potential explanation
for this difference is the higher proportion of failed
anterior transpositions (12 SCT and four SMT in
20 cases) in their series. In our study most patients
had previously undergone a SiD. Our feeling is that
the chance for success is higher for treatment of
incomplete release than extensive scar tissue. In
the other studies on SMT (Broudy et al. 1978; Gabel
and Amadio, 1990; Rogers et al. 1991; Vogel et al.,
2004), incomplete release was noted as the cause in
more than 50% of the cases.
The publications on recalcitrant CuTS are quite
heterogeneous. A wide range of different outcome
measures and follow-up periods were found. Some
reports have not defined which grading system was
applied. Only the studies by Caputo and Watson
(2000) and Gabel and Amadio (1990) have used the
same grading system. Gabel and Amadio (1990)
found satisfactory results after SMT in 83% and in
50% after SCT while Caputo and Watson (2000)
found 75% after SCT. It should be noted that there
were only three patients with muscle denervation in
the study by Caputo and Watson (2000) in contrast to
15 patients in the study by Gabel and Amadio (1990).
Denervation is a potentially negative prognostic
factor (Bartels et al., 2005; Gabel and Amadio,
1990). Gabel and Amadio (1990) presented a better
outcome for SMT than SCT, although the difference
did not reach statistical significance (p = 0.12). Most
studies have only looked at objective outcome meas-
ures. As Bartels and Grotenhuis (2004) have shown,
there may be a discrepancy between the objective
and subjective outcome after surgery. Patient satis-
faction is probably the most important outcome, and
therefore the result could be less favourable than
suggested by these studies. Our study demonstrated
almost similar objective and long-term subjective
outcomes. More research is needed to further inves-
tigate potential differences between the two types of
operation for recalcitrant CuTS, preferably in a pro-
spective or randomized controlled manner and
including patient reported outcome measures
(MacDermid and Grewal, 2013), strength and sens-
ibility measurements.
A drawback of the SMT is the relatively long period of
restriction of mobilisation after operation. In our study,
three elbow contractures were observed, of which two
resolved over time. Gabel and Amadio (1990) docu-
mented ten elbow contractures that all returned to
the preoperative level in six months. Although the
risk of this complication is low, it should be discussed
with the patient.
Limitations of our study include its retrospective
design with potential recall bias and that two
different surgeons carried out the surgery.
However, both surgeons performed exactly the
same procedure and have done a number of cases
together to assure this.
In conclusion, this study shows that SMT
with musculofascial lengthening is a good long-
term surgical option for persistent or recurrent
CuTS. There is no consensus in the literature about
which surgical technique (SCT or SMT) is best for
recalcitrant CuTS.
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